Table 2.
Carotid Endarterectomy (CEA) Study Collection and 30-day MAE Rates.
First author | Year | Total CEA | Octogenarians, N | Male | Mean age, y | Symptomatic | Nr of MAE's | MAE (%) |
---|---|---|---|---|---|---|---|---|
Lichtman [33] | 2010 | 140.376 | 140.376 | NR | 83.0 | NR | 3.088 | 2.2% |
Usman* [19] | 2009 | 7.017 | 7.017 | NR | 82.7 | 54% | 316 | 4.5% |
Halm [34] | 2009 | 9.308 | 2.198 | NR | NR | NR | 106 | 4.8% |
Bremner [35] | 2008 | 195 | 105 | 62% | 83.7 | 43% | 6 | 5.7% |
Ballotta [36] | 2006 | 1.260 | 112 | 62% | 84.2 | 66% | 1 | 0.9% |
Teso [37] | 2005 | 14.679 | 2.379 | 54% | NR | 11% | 100 | 4.2% |
Pulli [38] | 2005 | 1.883 | 149 | 70% | NR | NR | 1 | 0.6% |
Miller [39] | 2005 | 2.217 | 360 | NR | 83.6 | 59% | 15 | 4.2% |
Lau [40] | 2005 | 286 | 33 | 100% | 82.0 | 51% | 3 | 8.0% |
Grego [41] | 2005 | 1.733 | 125 | 66% | NR | 50% | 1 | 0.8% |
Durward [42] | 2005 | 1.800 | 26 | NR | 91.3 | 81% | 0 | 0.0% |
Varghese [43] | 2004 | 359 | 33 | 61% | NR | 76% | 3 | 8.8% |
Hingorani [44] | 2004 | 565 | 299 | 51% | NR | 43% | 8 | 2.7% |
Ballotta [45] | 2004 | 1.150 | 92 | 52% | 83.7 | 66% | 0 | 0.0% |
Witz [46] | 2003 | 360 | 47 | 66% | 82.0 | 51% | 4 | 8.3% |
Rockman [47] | 2003 | 698 | 161 | 52% | NR | 46% | 4 | 2.5% |
Pruner [48] | 2003 | 3.430 | 269 | 62% | 82.9 | 83% | 8 | 3.1% |
Norman [49] | 2003 | 2.023 | 151 | 67% | NR | NR | 4 | 2.6% |
Salameh [50] | 2002 | 293 | 42 | NR | NR | NR | 2 | 4.8% |
Ozsvath [52] | 2002 | 3.932 | 125 | 45% | 83.0 | 50% | 3 | 2.4% |
Metz [53] | 2002 | 32 | 32 | 50% | 82.0 | 100% | 1 | 3.2% |
Cartier [54] | 2002 | 475 | 65 | 51% | 82.6 | 76% | 2 | 2.8% |
Saha [51] | 2002 | 101 | 101 | NR | 86.5 | 71% | 3 | 3.0% |
Ommer [55] | 2001 | 2.262 | 70 | 63% | 82.9 | 74% | 3 | 4.2% |
Lepore [56] | 2001 | 366 | 42 | 63% | 82.8 | 40% | 1 | 2.4% |
Ting [57] | 2000 | 656 | 57 | 58% | 82.0 | 86% | 4 | 6.8% |
Schneider [58] | 2000 | 582 | 88 | 61% | 83.2 | 75% | 1 | 1.1% |
Maxwell [59] | 2000 | 2.398 | 187 | 47% | 83.0 | 65% | 8 | 4.1% |
Total incl. Lichtman et al | 200.436 | 154.741 | NR | 83.5 | 47% | 3.695 | 2.4% | |
Total excl. Lichtman et al | 60.060 | 14.365 | NR | 83.5 | NR | 606 | 4.2% |
30-day Mortality rates, stroke not analysed
** Meta-analysis of CAS vs. CEA in octogenarians
MAE: Major Adverse Events (disabling stroke, myocardial infarction or death)